Richard Moreau

Title: Richard Moreau: Innovator in Medical Prediction Methods

Introduction

Richard Moreau is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in predicting patient survival times. His innovative approach has the potential to improve patient care and outcomes for those suffering from serious health conditions.

Latest Patents

Richard Moreau holds a patent for "Methods for predicting the survival time of patients with decompensated alcoholic cirrhosis." This invention relates to a method that involves determining the expression level of OAS2 or MX2 in a sample of peripheral blood mononuclear cells obtained from the patient. The method compares the determined level with a predetermined reference value to conclude the patient's survival time. If the level is higher than the reference value, it indicates a short survival time, while a lower level suggests a longer survival time.

Career Highlights

Throughout his career, Richard Moreau has worked with esteemed institutions such as Assistance Publique-Hôpitaux de Paris and Université Paris Diderot-Paris 7. His work in these organizations has allowed him to collaborate with other professionals in the medical field, enhancing his research and innovation capabilities.

Collaborations

Richard Moreau has collaborated with notable colleagues, including Pierre-Emmanuel Rautou and Emmanuel Weiss. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Richard Moreau's innovative methods for predicting patient survival times represent a significant advancement in medical science. His work has the potential to greatly impact patient care and improve outcomes for individuals with decompensated alcoholic cirrhosis.